II Consensus of the Brazilian Society of Dermatology for the Treatment of Alopecia Areata

    December 2024 in “ Anais Brasileiros de Dermatologia
    Paulo Müller Ramos, Alessandra Anzai, Bruna Duque‐Estrada, Daniel Fernandes Melo, Flavia Sternberg, Leopoldo Duailibe Nogueira Santos, Lorena Dourado Alves, Fabiane Mulinari‐Brenner
    TLDR Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.
    The updated guidelines from the Brazilian Society of Dermatology for treating alopecia areata (AA) emphasize individualized treatment plans based on disease severity, assessed using the SALT score. Mild cases often use intralesional corticosteroids, while severe cases may require Janus Kinase inhibitors like baricitinib and ritlecitinib, which have shown efficacy in large clinical trials. The guidelines also address the psychosocial impact of AA, recommending psychological support and cosmetic camouflage to improve quality of life. Special considerations are given for children, with ritlecitinib approved for those aged 12 and older. The consensus aims to improve patient outcomes by providing clear treatment pathways informed by recent research.
    Discuss this study in the Community →

    Research cited in this study

    62 / 62 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    1 / 1 results